Latest stories on PHAT
Phathom Pharmaceuticals Q3 2026 Earnings Preview
Seeking Alpha50 · neutralearnings
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals Provides Update on FDA Litigation
GlobeNewswire42 · neutralgeneral
Phathom Pharmaceuticals Provides Update on FDA Litigation
Business Insider42 · neutralgeneral
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom falls as FDA sued over refusal to accept ANDA for generic Voquezna
Seeking Alpha34 · bearishgeneral
PHAT Stock Eyes Worst Day In Nearly Two Years After Generic Drug Maker Challenges Key Drug’s Exclusivity
Stocktwits News34 · bearishgeneral
Cantor sees low odds of suit leading FDA to reverse on Phathom exclusivity
The Fly63 · neutralanalyst
Phathom Pharmaceuticals gives update on litigation filed by BDR Pharmaceuticals
The Fly44 · neutralgeneral
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
GlobeNewswire44 · neutralgeneral
Phathom Pharmaceuticals Provides Update on Litigation Filed by BDR Pharmaceuticals against FDA
Business Insider44 · neutralgeneral
Phathom Pharmaceuticals price target lowered to $15 from $20 at Craig-Hallum
The Fly34 · bearishanalyst
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
Business Insider50 · neutralgeneral
Phathom Pharmaceuticals to Report Third Quarter 2026 Financial Results and Provide Business Update on Thursday, October 29, 2026
GlobeNewswire50 · neutralgeneral
Phathom Pharmaceuticals Highlights New Cost-Effectiveness Data and Growing Clinical Interest in VOQUEZNA® (vonoprazan) at ACG 2026
GlobeNewswire63 · neutralproduct/pr
Phathom Pharmaceuticals, Inc. (PHAT) files 8-K
SEC 8-K50 · neutralgeneral
Phathom Pharmaceuticals announces initiation of Phase 3 study of VOQUEZNA
The Fly63 · neutralproduct/pr
PHAT Stock Falls 7% As Leerink Sees Little Near-Term Upside — CEO Plays Down Upcoming Rival
Stocktwits News38 · neutralanalyst
Phathom Pharmaceuticals: Specialist Economics Strengthens The Bull Case
Seeking Alpha63 · neutralproduct/pr
Leerink starts Phathom Pharmaceuticals at Market Perform on limited upside
The Fly51 · neutralanalyst
Phathom Pharmaceuticals initiated with a Market Perform at Leerink
The Fly56 · neutralanalyst